Fig. 2From: Biosynthetic engineering of the antifungal, anti-MRSA auroramycinEngineering 3, 5-epi-lemonose biosynthesis. a Putative sugar biosynthesis pathway. b Liquid chromatography mass spectrometry (LCMS) spectra of extracts from engineered S. roseosporus strains with no modification to native BGC, (top) deletion of aurS9 and (middle) deletion of aurS11 (bottom) in the auroramycin BGCBack to article page